methylene blue has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Khorsandi, K; Kianmehr, Z; Yousefi Sadeghloo, A | 1 |
| Arini, GS; Baptista, MS; Bruni-Cardoso, A; de Almeida, DRQ; Dos Santos, AF; Gomes, VM; Inague, A; Labriola, L; Miyamoto, S; Pimentel, AC; Severino, D; Silva, RR; Terra, LF; Terra, WR; Wailemann, RAM; Yoshinaga, MY | 1 |
| Bhattacharjee, TT; Caetano Júnior, PC; Castilho, ML; Jesus, VPS; Lemes, GM; Raniero, L | 1 |
3 other study(ies) available for methylene blue and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Synergistic effect of photodynamic treatment and doxorubicin on triple negative breast cancer cells.
Topics: Antibiotics, Antineoplastic; Cell Death; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Female; Humans; Lasers; Methylene Blue; Photosensitizing Agents; Structure-Activity Relationship; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2020 |
Distinct photo-oxidation-induced cell death pathways lead to selective killing of human breast cancer cells.
Topics: Antioxidants; Breast Neoplasms; Carcinogenesis; Cell Death; Cell Line, Tumor; Female; Ferroptosis; Humans; Light; Lipids; Lysosomes; Methylene Blue; Models, Biological; Necroptosis; Oxidation-Reduction; Photochemotherapy; Triple Negative Breast Neoplasms | 2020 |
Nanoparticles of methylene blue enhance photodynamic therapy.
Topics: Adenocarcinoma; Apoptosis; Cell Line, Tumor; Cell Survival; Drug Delivery Systems; Gold; Humans; Metal Nanoparticles; Methylene Blue; Photochemotherapy; Photosensitizing Agents; Silver; Triple Negative Breast Neoplasms | 2018 |